Afuco™ Anti-FOLR1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-113)

CAT#: AFC-TAB-113

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to folate receptor 1. It is a monoclonal antibody which is being investigated for the treatment of ovarian cancer, It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.

Gene Expression
Figure 1 IF staining of human cell line HeLa Figure 2 RNA cell line category: Group enriched (HeLa, RPTEC TERT1)

Specifications

  • Immunogen
  • Gestational choriocarcinoma cell line, Lu-75.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • FC, IP, ELISA, Neut, FuncS, IF
  • Conjugate
  • Unconjugated
  • Generic Name
  • Farletuzumab
  • Related Disease
  • Ovarian cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • FOLR1; folate receptor 1 (adult); FOLR; folate receptor alpha; FR-alpha; KB cells FBP; folate binding protein; folate receptor, adult; adult folate-binding protein; ovarian tumor-associated antigen MOv18; FBP;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-113. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Farletuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Farletuzumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Farletuzumab"

DrugMonitor™ Anti-Farletuzumab Antibody (VS-1224-YC466)
Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody targeting the folate receptor alpha, developed for epithelial ovarian cancer treatment. The DrugMonitor™ Anti-Farletuzumab Antibody (VS-1224-YC466) is an anti-drug antibody (ADA) against Farletuzumab. This drug-based antibody is raised in mice immunized with the Farletuzumab. The anti-Farletuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Farletuzumab in samples.

See other products for "FOLR1"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
IAB-B029(A) Recombinant Anti-human FOLR1 Intrabody [(D-Arg)9] PCA, Neut, FuncS scFv-(D-Arg)9
IAB-B029(G) Recombinant Anti-human FOLR1 Intrabody [+36 GFP] WB, Neut, FuncS scFv-(+36GFP)
IAB-B029(T) Recombinant Anti-human FOLR1 Intrabody [Tat] WB, ICC, Neut, FuncS scFv-Tat
CAT Product Name Application Type
TAB-018CQ Human Anti-FOLR1 Recombinant Antibody (TAB-018CQ) ELISA, WB, IHC Chimeric (Rat/Human) IgG1, κ
TAB-018CQ-S(P) Human Anti-FOLR1 Recombinant Antibody; scFv Fragment (TAB-018CQ-S(P)) ELISA, WB, IHC Human scFv
TAB-018CQ-F(E) Human Anti-FOLR1 Recombinant Antibody; Fab Fragment (TAB-018CQ-F(E)) ELISA, WB, IHC Chimeric (Rat/Human) Fab
CAT Product Name Application Type
Gly-029LC-1 Recombinant Anti-Human FOLR1 Antibody (Fc glycosylation/Non fucosylated) ELISA Human antibody
CAT Product Name Application Type
MOR-1333 Hi-Affi™ Rabbit Anti-FOLR1 Recombinant Antibody (clone DS1333AB) WB Rabbit IgG
CAT Product Name Application Type
VS-0325-FY70 Human Anti-FOLR1 (clone Farletuzumab) scFv-Fc Chimera ELISA, Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC262 Recombinant Anti-FOLR1 Vesicular Antibody, EV Displayed (VS-0425-YC262) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-XY2606 Anti-FOLR1 Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0525-YC13 Recombinant Anti-FOLR1 Biparatopic Antibody, Asymmetric scFv-Fab ELISA Asymmetric scFv-Fab
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare